The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.

@article{Deabate2000TheSA,
  title={The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.},
  author={C A Deabate and Chavaramplakic P Mathew and John Harley Warner and A. Heyd and Deirdre Church},
  journal={Respiratory medicine},
  year={2000},
  volume={94 11},
  pages={1029-37}
}
Chronic bronchitis is common among adults and infectious exacerbations contribute considerably to morbidity and mortality. We aimed to compare the safety and efficacy of moxifloxacin to azithromycin for the treatment of patients with acute exacerbations of chronic bronchitis (AECB) of suspected bacterial origin. Between October 1998 and April 1999, 567… CONTINUE READING